The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

NCT02443194 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

50

Enrollment

OTHER_GOV

Sponsor class

Stopped principle investigator decision due to many adverse events in patients

Conditions

Depression

Interventions

DRUG: duloxetine
DRUG: PLACEBO

Sponsor

michal roll